Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records.

Saved in:
Bibliographic Details
Title: Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records.
Authors: Villanueva V; Refractory Epilepsy Unit, Hospital Universitario y Politécnico La Fe, EpiCARE member, Avenida Fernando Abril Martorell 106, 46026, Valencia, Spain. villanueva_vichab@gva.es., Laloyaux C; UCB Pharma, Brussels, Belgium., D'Souza W; Department of Medicine, St Vincent's Hospital Melbourne, The University of Melbourne, Melbourne, Australia., Faught E; Emory Epilepsy Center, Atlanta, GA, USA., Klein P; Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD, USA., Reuber M; The University of Sheffield, Sheffield, UK., Rosenow F; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, Center of Neurology and Neurosurgery, Frankfurt am Main, Germany., Salas-Puig J; Universitari Vall d'Hebron, Barcelona, Spain., Insuga VS; Pediatric Neurology, Hospital Universitario Infantil Niño Jesús, Madrid, Spain., Strzelczyk A; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, Center of Neurology and Neurosurgery, Frankfurt am Main, Germany., Szaflarski JP; University of Alabama at Birmingham (UAB) Heersink School of Medicine, Department of Neurology and UAB Epilepsy Center, Birmingham, AL, USA., Chinn C; UCB Pharma, Slough, England, UK., Daniels T; UCB Pharma, Morrisville, NC, USA., Floricel F; UCB Pharma, Monheim am Rhein, Germany., Friesen D; UCB Pharma, Slough, England, UK., Sendersky V; UCB Pharma, Brussels, Belgium., Besson H; UCB Pharma, Breda, The Netherlands., Steinhoff BJ; Kork Epilepsy Center, Kehl-Kork and Medical Faculty, University of Freiburg, Freiburg, Germany.
Source: CNS drugs [CNS Drugs] 2023 Sep; Vol. 37 (9), pp. 819-835. Date of Electronic Publication: 2023 Sep 09.
Publication Type: Review; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1179-1934
DOI:10.1007/s40263-023-01033-4